A shift in recent years toward the use of highly potent active pharmaceutical ingredients (HPAPIs) has led to a significant change in the way innovators are using small molecules to deliver patient therapies. With this change comes the requirement of significant planning, proper equipment, and facility design as well as implementation of the necessary procedures to safely handle HPAPI’s.This masterclass on containment provides all relevant information in terms of how to produce highly potent or highly hazardous pharmaceutical products. The case study on a risk assessment will provide the audience the tool on how to perform a risk assessment by themselves. Technical containment solutions together with their performance on the OSD or API process equipment will offer the audience an overview of what is on the market with detailed technical information. A containment case study based on the ISPE SMEPAC Good Practice Guide will round up the masterclass.EARLY BIRD OFFERS:BOOK BY JANUARY 29TH AND SAVE £100BOOK BY FEBRUARY 29TH AND SAVE £50To register visit the event website or call Fateja Begum on +44 (0) 20 7827 6184